RUNX2 and acute myeloid leukemia: In addition, different efficaciesof UCM-13369 were observed between both AML models, being higher inNPM1 C+ expressing cells (OCI-AML3: IC50 = 7.26 μM,MOLM13: IC50 = 10.89 μM, p-value≤0.01, Figure 3A).